- Home
- UHS vs PODD Comparison
UHS vs PODD Comparison
Compare UHS & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UHS
- PODD
- Stock Information
- Founded
- UHS 1978
- PODD 2000
- Country
- UHS United States
- PODD United States
- Employees
- UHS N/A
- PODD N/A
- Industry
- UHS Hospital/Nursing Management
- PODD Medical/Dental Instruments
- Sector
- UHS Health Care
- PODD Health Care
- Exchange
- UHS Nasdaq
- PODD Nasdaq
- Market Cap
- UHS 14.9B
- PODD 16.5B
- IPO Year
- UHS N/A
- PODD 2007
- Fundamental
- Price
- UHS $201.75
- PODD $260.12
- Analyst Decision
- UHS Buy
- PODD Buy
- Analyst Count
- UHS 17
- PODD 15
- Target Price
- UHS $227.31
- PODD $251.53
- AVG Volume (30 Days)
- UHS 831.1K
- PODD 609.1K
- Earning Date
- UHS 10-24-2024
- PODD 11-07-2024
- Dividend Yield
- UHS 0.40%
- PODD N/A
- EPS Growth
- UHS 57.82
- PODD 235.68
- EPS
- UHS 15.03
- PODD 5.74
- Revenue
- UHS $15,417,759,000.00
- PODD $1,983,900,000.00
- Revenue This Year
- UHS $11.17
- PODD $22.33
- Revenue Next Year
- UHS $6.34
- PODD $18.50
- P/E Ratio
- UHS $13.42
- PODD $45.35
- Revenue Growth
- UHS 9.93
- PODD 27.42
- 52 Week Low
- UHS $133.70
- PODD $160.19
- 52 Week High
- UHS $243.25
- PODD $279.40
- Technical
- Relative Strength Index (RSI)
- UHS 37.91
- PODD 63.27
- Support Level
- UHS $193.79
- PODD $233.48
- Resistance Level
- UHS $211.11
- PODD $276.57
- Average True Range (ATR)
- UHS 5.37
- PODD 8.53
- MACD
- UHS -0.39
- PODD 2.16
- Stochastic Oscillator
- UHS 43.31
- PODD 63.19
About UHS Universal Health Services Inc.
Universal Health Services Inc owns and operates acute care hospitals, behavior health centers, surgical hospitals, ambulatory surgery centers, and radiation oncology centers. The firm operates in two key segments: Acute Care Hospital Services and Behavioral Health Services. The Acute Care Hospital Services segment includes the firm's acute care hospitals, surgical hospitals, and surgery and oncology centers.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.